Semaglutide remains the most prescribed ADM medication, and tirzepatide continues to be the second-most prescribed medication (it surpassed dulaglutide in late 2023)
The clinical record shows: A 1 mg dose already produces meaningful weight-loss signal in Phase 2 data
Unimolecular peptides with dual GIP/GLP-1 receptor agonism have been developed to improve metabolic efficacy and therapeutic index beyond what incretin mono-agonists can achieve (44, 63)
Body contouring can be performed while patients are on GLP-1 medications, but coordination between the plastic surgeon and the prescribing physician is essential
What temperature is too hot for compounded semaglutide
If you have a serious adverse event that only happens after five years in one in 25,000 people, of course, you're not going to see that signal in a clinical trial, said Drucker